- Home
- BBAI vs SPRY Comparison
BBAI vs SPRY Comparison
Compare BBAI & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAI
- SPRY
- Stock Information
- Founded
- BBAI 2020
- SPRY 2015
- Country
- BBAI United States
- SPRY United States
- Employees
- BBAI N/A
- SPRY N/A
- Industry
- BBAI EDP Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- BBAI Technology
- SPRY Health Care
- Exchange
- BBAI Nasdaq
- SPRY Nasdaq
- Market Cap
- BBAI 1.0B
- SPRY 1.2B
- IPO Year
- BBAI N/A
- SPRY N/A
- Fundamental
- Price
- BBAI $3.25
- SPRY $13.49
- Analyst Decision
- BBAI Strong Buy
- SPRY Strong Buy
- Analyst Count
- BBAI 3
- SPRY 4
- Target Price
- BBAI $5.17
- SPRY $28.75
- AVG Volume (30 Days)
- BBAI 56.5M
- SPRY 1.3M
- Earning Date
- BBAI 05-01-2025
- SPRY 05-14-2025
- Dividend Yield
- BBAI N/A
- SPRY N/A
- EPS Growth
- BBAI N/A
- SPRY N/A
- EPS
- BBAI N/A
- SPRY 0.08
- Revenue
- BBAI $159,872,000.00
- SPRY $89,149,000.00
- Revenue This Year
- BBAI $9.65
- SPRY $1.49
- Revenue Next Year
- BBAI $12.82
- SPRY $141.68
- P/E Ratio
- BBAI N/A
- SPRY $169.75
- Revenue Growth
- BBAI 9.40
- SPRY 297063.34
- 52 Week Low
- BBAI $1.17
- SPRY $7.55
- 52 Week High
- BBAI $10.36
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- BBAI 51.52
- SPRY 47.20
- Support Level
- BBAI $2.96
- SPRY $13.45
- Resistance Level
- BBAI $3.58
- SPRY $15.06
- Average True Range (ATR)
- BBAI 0.26
- SPRY 0.71
- MACD
- BBAI 0.06
- SPRY -0.17
- Stochastic Oscillator
- BBAI 62.24
- SPRY 18.07
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.